title: [Long-term treatment with calcium antagonists: advantageous effects and risks].
authors.affiliation: Afd. Farmacotherapie, Academisch Medisch Centrum, Amsterdam.
authors.forename: P A
authors.initials: PA
authors.lastname: van Zwieten
authors.forename: J G
authors.initials: JG
authors.lastname: Tijssen
authors.forename: K I
authors.initials: KI
authors.lastname: Lie
authors.forename: P W
authors.initials: PW
authors.lastname: de Leeuw
mesh_terms: D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000209:etiology; D009543:Nifedipine / Q000009:adverse effects; D012189:Retrospective Studies; D012307:Risk Factors; D014700:Verapamil / Q000009:adverse effects
chemical_list: D002121:Calcium Channel Blockers; D014700:Verapamil; D009543:Nifedipine
vernacular_title: Langdurige behandeling met calciumantagonisten: nuttige effecten en risico's.